电子健康记录关联的青光眼用药提醒与患者满意度
这项前瞻性横断面研究纳入某大学青光眼门诊100例使用青光眼药物的患者,在电子健康记录(EHR)患者门户中配置电信提醒。94例完成配置,随访时74%认为提醒有用,81%在他人帮助下完成配置,提示EHR关联提醒可行且接受度良好。
要点
- 100例中94例最终配置提醒,89例完成随访。
- 随访时74%(95%CI 65-83)认为提醒有用。
- 81%(95%CI 77-85)在他人帮助下配置提醒。
核心结论
- EHR关联的青光眼用药提醒在三级青光眼门诊患者中配置率与接受度良好,但对青光眼结局的影响尚不明确。
研究设计与样本
- 前瞻性横断面研究,2017年4月至2018年1月从大学附属青光眼门诊招募使用青光眼药物的患者。
- 147例被接触者中100例(68%)同意参与,最终94例配置提醒、89例完成随访。
主要发现
- 参与者平均(SD)年龄65(12.4)岁,男性54例(54%),白人51例(51%)。
- 参与者自报用药依从率均值(SD)为91%(13.6%),未参与者为97%(6.0%)。
- 按既往验证的风险评分,参与者中9%(9/100)为依从性差高危(不依从概率≥50%),未参与者为11%(5/47)。
- 随访时74%(n=66;95%CI 65-83)认为提醒有用,15%(n=13)中立,11%(n=10)认为无用。
- 81%(72/89;95%CI 77-85)在帮助下配置提醒。
临床怎么用
- EHR患者门户可作为让患者将青光眼药物与自动提醒关联的便捷方式。
- 对高危不依从患者可考虑提供配置协助。
局限性
- 结果为单中心三级青光眼门诊人群,外推性未知。
- 对青光眼结局的影响尚不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: While dosing reminders for glaucoma medications have been shown to increase drug adherence, an outstanding limitation preventing broad adoption is difficulty linking reminders to medication in each patient's electronic health record (EHR). OBJECTIVE: To examine the feasibility of implementing an EHR-linked, automated reminder system for glaucoma medications and assess patient satisfaction with it. DESIGN, SETTING, AND PARTICIPANTS: In this prospective, cross-sectional study, patients receiving glaucoma medications were recruited from a university-based glaucoma clinic from April 2017 to January 2018. Analysis began in February 2018. EXPOSURES: A web-based application was added to the EHR patient portal, allowing patients to configure telecommunication-based reminders for their glaucoma medications. For all potential participants, basic information was collected to determine risk of nonadherence with glaucoma medications. Those consenting to participate then answered questions on medication adherence, reminders, and their likelihood of using EHR-linked reminders. They then configured reminders using the EHR patient portal. After 3 months, they answered questions about their satisfaction with the system. MAIN OUTCOMES AND MEASURES: Proportions of patients and high-risk patients willing to use the reminders, and patient satisfaction with the system. RESULTS: Of 147 patients approached, 100 (68%) agreed to participate, of whom the majority were men (54 [54%]) and white (51 [51%]), with a mean (SD) age of 65 (12.4) years. There were no differences between those willing and unwilling to participate, except for a slightly lower self-reported medication adherence rate among those who participated (mean [SD], 91% [13.6%] vs 97% [6.0%]). Based on a previously validated risk assessment score, 9% (9 of 100) of participants were categorized as being at high risk for poor adherence (≥50% probability of nonadherence) compared with 11% (5 of 47) of nonparticipants. Of 100 participants, 94 ultimately configured reminders, of whom 89 (95%) completed follow-up. On follow-up, 74% (n = 66; 95% CI, 65-83) of participants found the reminders to be useful, 15% (n = 13) were neutral, and 11% (n = 10) found them not useful. Most participants (72 [81%]; 95% CI, 77-85) had help configuring reminders. CONCLUSIONS AND RELEVANCE: Electronic health records-linked reminders had good uptake and were well received among patients at a tertiary glaucoma clinic. These portals may represent a new and convenient method of allowing patients to link their glaucoma medications to automated reminders, although the generalizability of these results and the effect on glaucoma outcomes remains unknown.
引用
- Varadaraj V, Friedman DS, Boland MV, et al. Association of an Electronic Health Record-Linked Glaucoma Medical Reminder With Patient Satisfaction. JAMA Ophthalmol. 2019. PMID: 30543342. doi:10.1001/jamaophthalmol.2018.6066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。